Parallel Advisors »

Kyverna Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $243 26 9.38

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Cvb Finl Corp Stock (CVBF)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Vanguard Large Cap Etf (VV)
Avantis International Equity Etf Etf (AVDE)
Ishares Core Msci Eafe Etf Etf (IEFA)

View all positions for Parallel Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics